Literature DB >> 7888259

Cholesterol lowering does have a role in secondary prevention.

D A Wood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7888259      PMCID： PMC483745          DOI： 10.1136/hrt.73.1.4

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  18 in total

1.  An overview of randomized trials of rehabilitation with exercise after myocardial infarction.

Authors:  G T O'Connor; J E Buring; S Yusuf; S Z Goldhaber; E M Olmstead; R S Paffenbarger; C H Hennekens
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

2.  The effect of warfarin on mortality and reinfarction after myocardial infarction.

Authors:  P Smith; H Arnesen; I Holme
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

3.  Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

Authors:  M L Burr; A M Fehily; J F Gilbert; S Rogers; R M Holliday; P M Sweetnam; P C Elwood; N M Deadman
Journal:  Lancet       Date:  1989-09-30       Impact factor: 79.321

4.  The Oslo diet-heart study. Eleven-year report.

Authors:  P Leren
Journal:  Circulation       Date:  1970-11       Impact factor: 29.690

5.  Beta blockade during and after myocardial infarction: an overview of the randomized trials.

Authors:  S Yusuf; R Peto; J Lewis; R Collins; P Sleight
Journal:  Prog Cardiovasc Dis       Date:  1985 Mar-Apr       Impact factor: 8.194

Review 6.  Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension.

Authors:  K Pyörälä; G De Backer; I Graham; P Poole-Wilson; D Wood
Journal:  Eur Heart J       Date:  1994-10       Impact factor: 29.983

7.  Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.

Authors:  P L Canner; K G Berge; N K Wenger; J Stamler; L Friedman; R J Prineas; W Friedewald
Journal:  J Am Coll Cardiol       Date:  1986-12       Impact factor: 24.094

8.  Effect of propranolol in postinfarction patients with mechanical or electrical complications.

Authors:  C D Furberg; C M Hawkins; E Lichstein
Journal:  Circulation       Date:  1984-04       Impact factor: 29.690

9.  Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid.

Authors:  L A Carlson; G Rosenhamer
Journal:  Acta Med Scand       Date:  1988

Review 10.  Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

Authors:  R Collins; R Peto; S MacMahon; P Hebert; N H Fiebach; K A Eberlein; J Godwin; N Qizilbash; J O Taylor; C H Hennekens
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321
View more
  3 in total

Review 1.  Management of lipid disorders in the elderly.

Authors:  D A Playford; G F Watts
Journal:  Drugs Aging       Date:  1997-06       Impact factor: 3.923

Review 2.  Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal.

Authors:  T R Pedersen; J A Tobert
Journal:  Drug Saf       Date:  1996-01       Impact factor: 5.606

Review 3.  The 4S study. Implications for prescribing.

Authors:  A J van Boven; J Brügemann; P A de Graeff; J F May; H J Crijns
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.